ALA in 100 mM Tris-Cl buffer, pH 9.6 for 3 min. The products formed were extracted with equal volumes of hexane: diethyl ether (1:1). The organic solvent was evaporated and dried products were then dissolved in HPLC mobile phase consisting of hexane: propane-2-ol: acetic acid in 1000:15:1 ratio for purification of these metabolites on HPLC. For biosynthesis of corresponding hydroxides, these dried hydroperoxy products were reduced with sodium borohydride (NaBH 4 ).
The metabolites were separated on semi preparative straight phase HPLC (Shimadzu LC 20AP, Shimadzu LC solution), using Enable Silica column (250x20mm) on the solvent system mentioned above at a flow rate of 6 ml/min. The samples were monitored at 235 nm and peaks were analysed on UV/VIS Perkin Elmer lambda35 spectrophotometer. The solvent evaporated and metabolites were stored in figure S6 . The metabolites were separated on analytical straight phase HPLC (Shimadzu LC 20AP, Shimadzu LC solution), using Silica column on hexane: propane-2-ol: acetic acid (1000:15:1) at 1 ml/min flow rate. The samples were monitored at 235 nm. Reduction of hydroperoxy metabolite (13-(S)-HPOTrE) into hydroxy metabolites (13-(S)-HOTrE), in complete medium (DMEM+10% FBS) was observed during incubation period and a significant amount of 13-(S)-HPOTrE was converted into 13-(S)-HOTrE at
